Next-generation sequencing and bioinformatics analysis in breast cancer research: Insights from Western Kazakhstan

Aitmagambetova M. Seidalin N. Babenko D. Smagulova G. Balmagambetova S. Koishybaev A. Tulyayeva A. Kereyeva N. Zholmukhamedova D. Zharylgapov A. Imanbayev N. Ablakimova N.
20 March 2025 AccScience Publishing

Eurasian Journal of Medicine and Oncology
2025 #9 Issue 1 92 - 107 pp.

Breast cancer (BC) is one of the most prevalent malignancies among women worldwide and a leading cause of cancer-related mortality. Studying gene mutations associated with BC risk in Kazakh women can help identify hereditary predispositions and facilitate early prevention. Next-generation sequencing (NGS) technology was used to sequence 113 candidate genes, followed by bioinformatics analysis, on BC patients from Western Kazakhstan. NGS sequencing revealed 28 polymorphisms from the genome-wide association studies catalog, seven of which were identified as statistically significant risk polymorphisms for BC: RARG (Rs2229774), FGFR2 (Rs2981582), ATM (Rs1800057), MAP3K1 (Rs889312), BRCA2 (Rs11571833), FGFR2 (Rs7895676), and FGFR2 (Rs1219648). Inheritance model analysis showed that the polymorphism in the Rs2981582 of the FGFR2 gene increased the likelihood of developing BC across four inheritance models. The Rs2229774 polymorphism of the RARG gene elevated BC risk in three models, whereas the Rs889312 polymorphism of the MAP3K1 gene did so in two models. The Rs137852985 polymorphism of the BRIP1 gene raised BC risk in four models, and Rs137852576 of the AR gene increased the risk in the codominant model. In a one-factor risk prediction, 32 significant factors were identified, with risks ranging from 69.7% to 90.6%. The combination of polymorphisms “Rs2229774 (AG),”“Rs889312 (AA, CC),” and “Age <54 years” yielded a high-risk assessment (95.8%), with a predictive quality score of 0.88. Overall, NGS sequencing identified six statistically significant gene polymorphisms (ATM Rs1800057, RARG Rs2229774, BRCA2 Rs11571833, MAP3K1 Rs889312, FGFR2 Rs2981582, and BRIP1 Rs137852985) associated with a high risk of BC in Kazakh women.

Bioinformatics analysis , Breast cancer , Genome-wide association study , Next-generation sequencing , Single-nucleotide polymorphism

Text of the article Перейти на текст статьи

Department of Oncology, West Kazakhstan Marat Ospanov Medical University, Aktobe, Kazakhstan
Department of Oncology, Hospital of the Medical Center of the Administration of the President of the Republic of Kazakhstan, Astana, Kazakhstan
Scientific Research Center, Karaganda Medical University, Karaganda, Kazakhstan
Department of Pharmacology, Clinical Pharmacology, West Kazakhstan Marat Ospanov Medical University, Aktobe, Kazakhstan
Department of Hospital Pharmacy, Regional Perinatal Center, Aktobe, Kazakhstan

Department of Oncology
Department of Oncology
Scientific Research Center
Department of Pharmacology
Department of Hospital Pharmacy

10 лет помогаем публиковать статьи Международный издатель

Книга Публикация научной статьи Волощук 2026 Book Publication of a scientific article 2026